| Howyda Beydoun, | |
|
7555 Telegraph Rd, Taylor, MI 48180-2239 | |
| (313) 292-5014 | |
| Not Available |
| Full Name | Howyda Beydoun |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7555 Telegraph Rd, Taylor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124629068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5302032631 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Howyda Beydoun, 145 Rosemary St, Dearborn Hts, MI 48127-3625 Ph: (313) 282-4902 | Howyda Beydoun, 7555 Telegraph Rd, Taylor, MI 48180-2239 Ph: (313) 292-5014 |
News Archive
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of Spectrum Two™, a reliable infrared (FT-IR) spectrometer built upon decades of spectroscopy expertise. Part of a new platform of FT-IR spectrometers, Spectrum Two is designed specifically to perform rapid analytical measurements and is suited to a wide range of materials and markets.
Scientists have identified a group of small molecules that interfere with the activity of a compound that initiates multiple steps in blood clotting, including those that lead to the obstruction of veins or arteries, a condition called thrombosis. Blocking the activity of this compound, polyphosphate, could treat thrombosis with fewer bleeding side effects than the drugs that are currently on the market.
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an investigational therapy in patients with previously treated EGFR mutant-positive non-small cell lung cancer.
› Verified 5 days ago
Robert Michael Armstrong, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22525 Wick Rd, Taylor, MI 48180 Phone: 313-292-3755 Fax: 313-292-3784 | |
Dr. Karen Marie Harven, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15009 Telegraph Rd, Taylor, MI 48180 Phone: 734-374-2101 Fax: 734-374-2360 | |
Soma Aqeel Mirza, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15549 Dupage Blvd, Taylor, MI 48180 Phone: 734-308-7263 | |
Mrs. Anne Dodt, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14640 Pardee Rd, Taylor, MI 48180 Phone: 734-374-4233 Fax: 734-374-4265 | |
Daniel James Lobb, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22525 Wick Rd, Taylor, MI 48180 Phone: 313-292-3755 Fax: 313-292-3784 | |
Andrea M Molnar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14099 Pardee Rd, Taylor, MI 48180 Phone: 734-288-0005 Fax: 734-286-9638 | |
Mrs. Wafa A Moughni-ayad, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20090 Goddard Rd, Taylor, MI 48180 Phone: 313-299-1584 |